Theradex Oncology is a full-service, oncology-focused clinical trial provider serving the global pharma/biotech industry and the US NCI for more than 40 years. With offices in Princeton, London and Gothenburg, Sweden, we have managed more than 350 sponsor-led trials in North America, Europe and Asia ranging from early to late phase and supported over 2000 trials with our data management, monitoring and auditing expertise developing strong relationships with regulators and sites along the way.

The combination of Medical, Regulatory and Operational Expertise enable Emerging Biotech to thrive by fostering a flexible, nimble structure with our backbone of 40+ years of experience. Theradex Oncology has long term senior managers including US and EU regulatory experts, MD medical oncologists with decades of experience conducting oncology clinical trials and operational teams with an average of 7 years of oncology experience.

For many projects, we guide emerging biotech sponsors through the pre IND and IND submission process and assist for protocol design and development for all clinical phases. Our oncologists work hand-in-hand with the operational team for seamless study execution. Our approach and way of working is collaborative as we navigate regulatory hurdles, overcome complex medical challenges, and execute each study seamlessly as a true partner.